Further, there were no substantial differences in the genomic scores between CD cases diagnoses with different diagnosis methods (Additional file 1: Supplementary Results and Figure S4).
There were no substantial differences between the groups, neither in CHF etiology nor in the different types of medical therapy.
While there were no substantial differences in the 3ʹUTR, all groups of transcripts regulated by Xrn1 had a significantly higher PARS score in the CDS (0.32 0.35) compared to transcripts not significantly affected by Xrn1 (0.25) (Fig. 6b).
Interestingly, in our culture system, there were no substantial differences in chondrogenic marker gene transcription between samples exposed to uniaxial shear or compressive stimulation, nor to biaxial stimulation (Fig. 3).
For-profit entrepreneurs took the broadest academic programs, but there were no substantial differences between nonprofit entrepreneurs and wage workers.
There were no substantial differences in the pooled sensitivity and specificity for cutoff scores from 7 to 10.
However, there were no substantial differences in how patients described these symptoms in relation to onset, severity, frequency and duration.
In conclusion, there were no substantial differences between bolus injection and continuous infusion of equal doses of furosemide for the treatment of patients hospitalized with heart failure.
Our findings demonstrate that there were no substantial differences in the symptoms or domains of impact experienced by patients with ACO or COPD alone.
For the impact of symptoms on patients' daily lives, there were no substantial differences in the domains of impact experienced by patients with ACO or COPD (Fig. 2).
There were no substantial differences in the risk of MI or heart failure between participants using donepezil and those using other cholinesterase inhibitors (all hazard ratios (HR) crossing 1).
